CN Stock MarketDetailed Quotes
603193 Runben Biotechnology
- 25.93
- +0.82+3.27%
Not Open Nov 14 15:00 CST
10.49BMarket Cap34.25P/E (TTM)
27.62High24.28Low114.71KlotVolume24.30Open25.11Pre Close306.28MTurnover11.10%Turnover Ratio46.39P/E (Static)404.59MShares27.6252wk High5.14P/B2.68BFloat Cap11.5752wk Low27.62Limit Up103.34MShs Float27.62Historical High22.60Limit Down13.30%Amplitude11.57Historical Low0.35Dividend TTM26.70Avg Price71.04KlotAsk1.35%Div YieldTTM100Lot Size35.04KlotBid
Runben Biotechnology Key Stats
EPS
According to the latest financial report of Runben Biotechnology, the latest earnings per share (TTM) for the company is 0.64. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Runben Biotechnology's latest financial report to see how much their book value per share (BVPS) is currently at 5.04.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Runben Biotechnology shows that the company's current ratio is 10.60, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Runben Biotechnology, the quick ratio is 9.90, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Runben Biotechnology? The latest ROE figure is 13.17%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Runben Biotechnology, the total asset return on investment (ROA) is 12.31%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Runben Biotechnology's latest financial report to see how their gross margin is doing - currently at 58.33%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Runben Biotechnology, the net profit margin is 25.15%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data